Fort L.P. increased its position in Clorox Co (NYSE:CLX) by 35.0% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 15,375 shares of the company’s stock after buying an additional 3,988 shares during the period. Fort L.P.’s holdings in Clorox were worth $2,467,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently modified their holdings of CLX. Oregon Public Employees Retirement Fund grew its stake in shares of Clorox by 48,033.6% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 6,808,980 shares of the company’s stock valued at $44,000 after buying an additional 6,794,834 shares during the period. Norges Bank acquired a new stake in shares of Clorox in the 4th quarter valued at about $175,485,000. BlackRock Inc. grew its stake in shares of Clorox by 7.7% in the 4th quarter. BlackRock Inc. now owns 10,555,837 shares of the company’s stock valued at $1,627,074,000 after buying an additional 752,085 shares during the period. Janus Henderson Group PLC grew its stake in shares of Clorox by 28.4% in the 1st quarter. Janus Henderson Group PLC now owns 1,771,185 shares of the company’s stock valued at $284,204,000 after buying an additional 391,569 shares during the period. Finally, Geode Capital Management LLC grew its stake in shares of Clorox by 21.5% in the 4th quarter. Geode Capital Management LLC now owns 1,899,544 shares of the company’s stock valued at $292,347,000 after buying an additional 335,835 shares during the period. Institutional investors own 77.67% of the company’s stock.
In other Clorox news, SVP Denise Garner sold 20,399 shares of Clorox stock in a transaction that occurred on Friday, June 7th. The shares were sold at an average price of $157.61, for a total transaction of $3,215,086.39. Following the transaction, the senior vice president now owns 4,896 shares of the company’s stock, valued at approximately $771,658.56. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 1.40% of the stock is owned by company insiders.
Clorox stock opened at $155.98 on Friday. Clorox Co has a 52 week low of $125.40 and a 52 week high of $167.70. The company has a current ratio of 1.10, a quick ratio of 0.66 and a debt-to-equity ratio of 2.93. The company has a market cap of $19.99 billion, a price-to-earnings ratio of 24.92, a PEG ratio of 4.57 and a beta of 0.38.
Clorox (NYSE:CLX) last posted its earnings results on Wednesday, May 1st. The company reported $1.44 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $1.47 by ($0.03). Clorox had a return on equity of 108.82% and a net margin of 12.68%. The firm had revenue of $1.55 billion for the quarter, compared to the consensus estimate of $1.57 billion. During the same period in the prior year, the business earned $1.37 EPS. Clorox’s quarterly revenue was up 2.2% compared to the same quarter last year. As a group, sell-side analysts expect that Clorox Co will post 6.29 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Friday, August 16th. Shareholders of record on Wednesday, July 31st will be given a dividend of $1.06 per share. The ex-dividend date is Tuesday, July 30th. This represents a $4.24 annualized dividend and a dividend yield of 2.72%. This is a boost from Clorox’s previous quarterly dividend of $0.96. Clorox’s dividend payout ratio (DPR) is currently 61.34%.
CLX has been the topic of several recent research reports. Zacks Investment Research raised shares of Clorox from a “hold” rating to a “buy” rating and set a $177.00 price target on the stock in a research report on Monday, March 11th. Wells Fargo & Co reaffirmed a “hold” rating and issued a $157.00 price target on shares of Clorox in a research report on Thursday, February 21st. Credit Suisse Group initiated coverage on shares of Clorox in a research report on Wednesday, March 6th. They issued an “outperform” rating and a $172.00 price target on the stock. Argus cut shares of Clorox from a “buy” rating to a “hold” rating in a research report on Monday, May 20th. Finally, JPMorgan Chase & Co. cut shares of Clorox from a “neutral” rating to an “underweight” rating and dropped their price target for the company from $159.00 to $139.00 in a research report on Monday, April 8th. Four research analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have assigned a buy rating to the stock. The stock has an average rating of “Hold” and a consensus price target of $149.29.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
Featured Article: Moving Average (MA)
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.